Abstract Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. offering hope for various malignancies by enhancing the immune response against tumors. However. ICIs are associated with unique immune-related adverse events (irAEs). https://medicalwarehouses.shop/product-category/orthopedic-supplies/